Zobrazeno 1 - 5
of 5
pro vyhledávání: '"623"'
Autor:
Odler, B.1, Bikov, A.1, Streizig, J.1, Balogh, C.1, Kiss, E.2, Vincze, K.1, Barta, I.3, Horváth, I.1,3, Müller, V.1 muller.veronika@med.semmelweis-univ.hu
Publikováno v:
Lupus. May2017, Vol. 26 Issue 6, p572-579. 8p. 3 Charts, 1 Graph.
Autor:
Budhram, A1, Chu, R2, Rusta-Sallehy, S3, Ioannidis, G4, Denburg, JA5, Adachi, JD4, Haaland, DA6
Publikováno v:
Lupus. Oct2014, Vol. 23 Issue 11, p1156-1163. 8p. 1 Diagram, 4 Charts.
Publikováno v:
Lupus. May2013, Vol. 22 Issue 6, p614-623. 10p. 2 Charts, 4 Graphs.
Autor:
Juang, Y.-T.1, Peoples, C.1, Kafri, R.2, Kyttaris, V. C.1, Sunahori, K.1, Kis-Toth, K.1, Fitzgerald, L.1, Ergin, S.1, Finnell, M.1, Tsokos, G. C.1 gtsokos@bidmc.harvard.edu
Publikováno v:
Lupus. Mar2011, Vol. 20 Issue 3, p243-249. 7p. 2 Charts, 4 Graphs.
Publikováno v:
Lupus. 26(1)
This report evaluates the effects of blisibimod (A-623, AMG 623), a potent and selective inhibitor of B-cell activating factor (BAFF), on patient-reported fatigue and disease activity in the Phase 2b PEARL-SC clinical trial in patients with systemic